Ultrasound Obstet Gynecol 2010; 36: 93–111 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.7622 The fetal venous system, Part II: ultrasound evaluation of the fetus with congenital venous system malformation or developing circulatory compromise S. YAGEL*#, Z. KIVILEVITCH†#, S. M. COHEN*, D. V. VALSKY*, B. MESSING*, O. SHEN* and R. ACHIRON‡ *Obstetrics and Gynecology Ultrasound Center, Hadassah-Hebrew University Medical Centers, Mt Scopus, Jerusalem, †Ultrasound Unit, Negev Medical Center, Macabbi Health Services, Beer Sheba and ‡Ultrasound Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv, Israel K E Y W O R D S: 3D/4DUS; fetal physiology; fetal venous system; IUGR; prenatal diagnosis; venous Doppler; venous malformations ABSTRACT The human fetal venous system is well-recognized as a target for investigation in cases of circulatory compromise, and a broad spectrum of malformations affecting this system has been described. In Part I of this review, we described the normal embryology, anatomy and physiology of this system, essential to the understanding of structural anomalies and the sequential changes encountered in intrauterine growth restriction and other developmental disorders. In Part II we review the etiology and sonographic appearance of malformations of the human fetal venous system, discuss the pathophysiology of the system and describe venous Doppler investigation in the fetus with circulatory compromise. Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. CONGENITAL ANOMALIES O F T H E F E T A L V E N O U S S Y S T E M: ETIOLOGY AND SONOGRAPHIC APPEARANCE Abnormal development of the fetal venous system can stem from any of its four embryonic systems: the umbilical, vitelline, cardinal and pulmonary systems. We speculate that the normal developmental course of the fetal venous system may be disturbed in two ways: (a) by primary failure of a system or part of a system to form or to create critical anastomoses, or (b) by secondary occlusion of an already transformed system. We1,2 have proposed a classification of fetal venous system anomalies that expands on the four major embryonic groups mentioned above. Classification system of fetal venous system anomalies A. Cardinal veins a. Complex malformations: heterotaxy syndromes. b. Isolated malformations: e.g. persistent left superior vena cava (PLSVC) or double superior vena cava (SVC), interrupted inferior vena cava, persistent left inferior vena cava, double inferior vena cava. B. Umbilical veins a. Primary failure to create critical anastomoses: abnormal connection of umbilical vein (UV) with agenesis of ductus venosus (DV) (with intra- or extrahepatic systemic shunt of the UV). b. Persistent right UV with or without left UV and/or DV. c. UV varix. C. Vitelline veins a. Primary failure to create critical anastomoses i. Complete agenesis of portal system (portosystemic shunt) ii. Partial agenesis of right or left or both portal branches (portohepatosystemic shunt) D. Anomalous pulmonary venous connection a. Total anomalous pulmonary venous connection b. Partial anomalous pulmonary venous connection Correspondence to: Prof. S. Yagel, Hadassah University Hospital, Mt Scopus - Obstetrics and Gynecology, PO Box 24035, Jerusalem, Mt. Scopus 91240, Israel (e-mail: [email protected]) #S.Y. and Z.K. contributed equally to this article. Accepted: 5 February 2010 Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. REVIEW 94 Yagel et al. Cardinal veins Heterotaxy syndromes Heterotaxy syndromes, or incomplete errors of lateralization, involve abnormal placement of some organs due to a failure to establish normal left–right patterning. It is important to differentiate these anomalies from complete situs inversus, in which all organs (visceral and thoracic) are rotated to the opposite side, and which is usually asymptomatic. Therefore, the first step in evaluating venous system malformations is to determine the fetal visceral and thoracic situs. The incidence of heterotaxy syndromes in newborns is approximately 1 : 10003,4 , and they constitute 2–4% of all congenital heart diseases (CHD)5 . These syndromes present in two main forms: asplenia and polysplenia syndromes. Asplenia is characterized by predominant right-sidedness and right atrial isomerism, resulting in a fetus whose left side is a mirror image of its right side. Congenital heart malformations are frequent (occurring in 50–100% of cases) and severe and represent the most important prognostic factors. The most frequent venous system malformations associated with asplenia include: PLSVC, anomalous pulmonary venous return and left sided inferior vena cava (IVC), resulting in a characteristic juxtaposition of the abdominal aorta and IVC. Polysplenia is characterized by predominant leftsidedness and left atrial isomerism, resulting in a fetus whose right side is a mirror image of its left side. Associated cardiac malformations are rare and less severe than in asplenia, the most common being atrioventricular septal defect with complete heart block. The characteristic venous malformation is an interrupted IVC with azygos continuation to the SVC. This anomaly arises from a failure to form the right subcardinal–hepatic anastomosis, resulting in absence of the hepatic segment of the IVC. The sonographic landmark is a dilated azygos vein alongside the aorta on the abdominal circumference plane and four-chamber view plane, and atrioventricular block bradycardia. In the sagittal abdominal plane the descending aorta and azygos vein run side-by-side with opposite directions of flow (Figure 1). Interrupted IVC has also been reported as an isolated entity6 – 10 . In such cases it is usually clinically silent. Persistent left superior vena cava (PLSVC) PLSVC is a known variant of venous return observed in 0.3% of adults without cardiac malformation and in approximately 4% of adults with CHD11 . Galindo et al.12 found a prevalence of 0.2% in fetuses with normal hearts, and 9% of fetuses with cardiac anomalies, in a population referred for echocardiographic examination in a tertiary center, calculating an odds ratio for CHD of 49.9 for a fetus with PLSVC. PLSVC is a remnant of the proximal segment of the left anterior cardinal vein (LACV), resulting from failure of the LACV to atrophy following formation of the oblique anastomosis with the right cardinal vein (the Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Figure 1 Interrupted inferior vena cava with azygos continuation imaged in high-definition power flow Doppler (HDPD) (a) and in B-flow (b). Note the dilated azygos vein (Az) draining into the superior vena cava (SVC), with flow in the opposite direction to the flow in the aorta (Ao). Compare with insets showing HDPD and B-flow images of the normal heart and great vessels. DV, ductus venosus; LHV, left hepatic vein. (Insets reproduced with permission from Yagel et al.75 ). innominate vein) (Figure 2). The vessel most often drains into the coronary sinus13,14 . It is diagnosed by fetal echocardiography on observation of a dilated coronary sinus (though this may not always be present) and an extraneous vessel identified to the left of the ductal arch in the three-vessels and trachea (3VT) view of the fetal heart. In very rare instances, PLSVC may be seen with absent right SVC15 ; in this case the 3VT view shows three vessels: the LSVC, ductal arch and aortic arch16 . Multiplanar Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 95 Figure 2 Persistent left superior vena cava imaged in gray-scale (a) and with color Doppler (b). In (c) the dilated coronary sinus is visible (CS and arrows), where the persistent left superior vena cava (LSVC) drains into it. Ao, aorta; MPA, main pulmonary artery; RSVC, right superior vena cava; Tr, trachea. reconstruction mode in 4D ultrasound has been shown to be useful in diagnosis of the PLSVC anomaly17 . When isolated, PLSVC usually has no clinical significance; however, it has been reported to occur in isolation in only 9% of cases. It is more often seen in association with other anomalies: both cardiac (23% of PLSVC cases), including atrioventricular septal defect, double-outlet right ventricle, left outflow tract obstructive anomalies, conotruncal anomalies and ventricular septal defect, and other extracardiac malformations, including heterotaxy syndrome (41–45%), esophageal atresia, diaphragmatic hernia, IVC malformations, complex malformation syndromes and chromosomal anomalies. There may be significant morbidity and mortality, arising from the associated anomalies rather than the lesion itself12,18 . Other very rare anomalies of the vena cava have been reported in the pediatric literature and extensively reviewed19 . Umbilical veins Anomalies of the umbilical and portal veins constitute the largest group of congenital venous anomalies detected in-utero. They include three main entities: agenesis of the DV with extrahepatic umbilicosystemic shunt or with intrahepatic umbilicohepatic shunt; persistent right UV (PRUV) with or without intact DV; UV varix. Agenesis of the ductus venosus Agenesis of the DV results from failure to form the ‘critical anastomosis’: no connection is established between the UV and DV, and this in turn leads to shunting of umbilical blood through an aberrant vessel that may flow either into extrahepatic veins such as the iliac vein, IVC, SVC, right atrium20 – 27 or coronary sinus28 , or via an intrahepatic venous network (umbilicohepatic shunt), through the portal sinus to the hepatic sinusoid (umbilicoportal–hepatic shunt) or even directly into the right atrium (Figure 3). The prevalence of the anomaly has been estimated at 6 : 1000 fetal examinations29 . It is often (in 24–65% of cases) associated with cardiac, extracardiac and chromosomal Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. anomalies, and syndromes such as Noonan syndrome. It is associated with agenesis of the portal vein in as many as 50% of cases, and may be associated in other cases with partial or total agenesis of the portal system. Hydrops and generalized edema occur in 33–52% of cases30,31 , and may require postnatal device occlusion29 . DV agenesis presents as an isolated finding in only 35–59% of cases. In such cases, however, 80–100% have normal outcome30 – 32 . While only sporadic cases were reported in neonates before the advent of ultrasound, prenatal sonographic diagnosis of DV agenesis is feasible and many case series have appeared in the literature2 . Among fetuses with no or minor associated anomalies, location of the umbilical drainage site seems to impact on prognosis, with a better outcome expected in cases without liver bypass22,31 – 34 . Jaeggi et al.22 reported 12 cases of agenesis of the DV with extrahepatic shunt and reviewed a further 17 from the literature. They reported a mortality rate of 17% from congestive heart failure in cases with extrahepatic shunt. Associated malformations were reported in 87% of the cases, single umbilical artery being the most common. Berg et al.31 reported 23 cases of agenesis of the DV, four with extrahepatic drainage and 19 with drainage of the umbilical vein into the portal sinus. Fifteen of the 23 fetuses had associated chromosomal or structural anomalies that impacted outcome. Among the subgroup of fetuses (8/23) with no or minor associated malformations, outcome was significantly better among those without liver bypass. They reported a total of 19 cases with intrahepatic drainage and no or minor associated anomalies, all of which survived, while only 20/29 with extrahepatic drainage and no or minor associated anomalies survived. Fetuses with extrahepatic drainage have a higher risk of congestive heart failure, even in the absence of cardiovascular anomaly. In reviewing their and published cases the authors determined that findings of cardiac malformations, complex non-chromosomal malformation syndromes and hydrops were predictive of in-utero or neonatal demise, whether drainage was intraor extrahepatic31 . From our observations we suggest that the parameter that most influences outcome in cases of agenesis of the DV is the development of the portal system. We recently Ultrasound Obstet Gynecol 2010; 36: 93–111. 96 presented data that support the notion that if the shunt is a narrower, ductus-like connection, some or all of the portal system will have developed. This in turn impacts on prognosis35 . Persistent right umbilical vein (PRUV) In the course of normal embryonic development, the right UV degenerates and the left UV is left to carry blood from the placenta to the fetus. Failure of right UV involution results in the PRUV anomaly1,36 – 39 (Figure 4). PRUV is the most frequently detected fetal venous system anomaly. Its prevalence has been estimated to range Yagel et al. from 1 : 250 to 1 : 57037,39 – 42 . It may replace the left UV, or be found as an intrahepatic supernumerary vein, connecting to the right portal vein. It may also bypass the liver, causing aberrant drainage of blood into the IVC or right atrium40,43,44 . It has been suggested that primary or secondary occlusion by thromboembolic events arising from the placenta may lead to early streaming of blood through the right UV to cause this anomaly45 . Teratogenic agents such as retinoic acid or deficient folate induced the PRUV anomaly in rats46 . Secondary formation of UV anomalies may result from thromboembolic events occluding the DV or other veins. Figure 3 (Continued over). Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 97 Figure 3 (Continued) Variations of agenesis of the ductus venosus (DV). (a–c) Case of agenesis of the DV with narrow extrahepatic shunt from the umbilical vein (UV) to the inferior vena cava (IVC), imaged with highdefinition power flow Doppler (HDPD) (a,c) and B-flow (b). In (c) the appropriately developed portal system is shown. (Az, azygos vein; LHV, left hepatic vein; LPV, left portal vein; MHV, main hepatic vein; RPVa and p, anterior and posterior branches of right portal vein; St, stomach.) (d–g) Complex case of agenesis of the DV with extrahepatic shunt, complicated with interrupted IVC. (d) HDPD image showing the UV draining into the shunt, between the IVC and Az. Note the Az is behind the aorta (red) Int-I, internal iliac vein. (e) B-flow image which helps to demonstrate the interrupted IVC with Az continuation, and the point of communication of the UV to the IVC at this connection. Note that there are almost no blood vessels in the area of the liver, which further suggests agenesis of the portal system. (f,g) Tomographic ultrasound imaging showing sequential sagittal planes, confirming the agenesis of the DV and interrupted IVC. The image in (f) is slightly lateral to the left of that in (g). AoA, aortic arch; dAo, descending aorta; Az, azygos; CT, celiac trunk; DA, ductus arteriosus; MPA, main pulmonary artery. (h,i) Another case of agenesis of the DV with intrahepatic shunt of the UV to the right hepatic vein (RHV), imaged in HDPD and B-flow. (j) 4D ultrasound B-flow image of absent DV, with UV drainage to the right atrium (RA). Ao, aorta; HV, hepatic veins; UC, umbilical cord. (Reproduced with permission from Yagel et al.134.) (k) Agenesis of the DV with partial agenesis of the portal system. Inversion mode in three-dimensional rendering demonstrating the umbilicoiliac shunt (carets). UA, umbilical artery. (Reproduced with permission from Achiron et al.55). Figure 4 Typical appearance of persistent right umbilical vein (UV). (a) The UV is seen passing laterally right of the gall bladder (GB). (b) The portal vein presents a mirror image of its normal anatomical configuration. The left portal vein (LPV) assumes the right portal vein (RPV) bifurcation, and its lateral branches change sides, the right side having the inferior (LPVi) and superior (LPVs) branches, and the left side having only one lateral branch. The ductus venosus (DV) has its origin to the left of the UV axis. (c) The main portal vein (MPV) is connected to the RPV in a more inferior plane relative to its normal position. LPVm, left portal vein medial branch; ST, stomach; SP, spine; Ao, aorta. Echogenic foci situated within the fetal liver suggest this etiology. Two of the 74 cases of PRUV reviewed by De Catte et al. had Noonan syndrome, and one had trisomy 18, all Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. with multiple associated anomalies47 . While early reports seemed to indicate that PRUV was a worrisome finding in prenatal ultrasound43,45 , accumulated experience has shown that in the absence of other anomalies intrahepatic Ultrasound Obstet Gynecol 2010; 36: 93–111. 98 Yagel et al. PRUV with normal DV connection is usually a normal anatomical variant with no clinical significance37,39,40,42 . Ultrasound identification of PRUV is made by visualizing the aberrant vein passing laterally to the right of the gall bladder in the plane of measurement of the abdominal circumference (Figure 4a). Fetal intra-abdominal umbilical vein varix Umbilical vein varix is a focal dilatation of vein. It is an uncommon finding, with an estimated intrauterine incidence of about 1 : 100048 . Most reported UV varices are of the intra-abdominal UV, but extra-abdominal UV varices have been reported49 . Fetal intra-abdominal UV (FIUV) varix is diagnosed when a sonographically anechoic cystic mass is seen between the abdominal wall and lower liver edge. Color Doppler ultrasonography helps to distinguish this vascular anomaly from other cystic lesions in this area (Figure 5). The diameter of most varices ranges between 8 and 14 mm50 and FIUV varix has been variously defined as an intra-abdominal UV diameter at least 1.5 times greater than the diameter of the intrahepatic UV51 , or as an intra-abdominal UV diameter exceeding 9 mm52 . In a review of 91 cases, Fung et al.53 reported that 68% presented as an isolated finding, and of these 74% had a normal outcome. However, 8.1% (5/62) resulted in intrauterine death in which no specific cause could be identified and one (1.6%) case had trisomy 21. In the group with associated sonographic findings, only 27.6% had normal outcome. Congenital abnormalities and syndromes were confirmed after birth in 20.7% (6/29), while 27.6% had chromosomal abnormalities. The overall incidence of aneuploidy was 9.9%, the majority being trisomy 21 or 18. The incidence of sudden intrauterine demise was 5.5%, occurring between 29 and 38 weeks of gestation. The diameter of the UV at first diagnosis and the maximum diameter of the UV over the course of pregnancy were not found to be related to the occurrence of obstetric complications53 . Diagnosis of FIUV varix warrants a detailed anatomical search for additional anomalies, karyotyping, echocardiography, and close monitoring of the fetus for sonographic signs of hemodynamic disturbance. Fetal heart monitoring is advised from 28 weeks of gestation. The optimal timing for delivery remains the subject of debate. In light of the apparent high risk of unfavorable outcome, including sudden intrauterine demise even in isolated FIUV varix, the option of induction of labor when lung maturity is ascertained may be considered54 . Vitelline veins Complete or incomplete agenesis of the portal system Anomalies of the vitelline veins are extremely rare, and few cases during fetal life have been reported55 – 59 . Morgan and Superina60 proposed classifying portal agenesis Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Figure 5 Fetal intra-abdominal umbilical vein (UV) varix: an anechoic cystic mass (calipers) is seen between the abdominal wall and the lower liver edge in a longitudinal section (a) and imaged with high-definition power flow Doppler (b). The varix is shown to be 1.5 times the diameter of the UV. Bl, bladder. into two types: Type I, in which there is complete diversion of the portal blood into the vena cava (portosystemic shunt); and Type II, in which the portal veins are preserved but a portion of portal blood is diverted into the systemic venous circulation through the liver (portohepatic shunt). Both types were further classified into two subtypes: Subtype a, in which the splenic vein (SpV) and superior mesenteric vein (SMV) do not join to form a confluence, and thus there is no anatomical portal vein; and Subtype b, in which the SpV and SMV do join to form a confluence that may shunt to the IVC, renal vein, iliac vein, azygos vein or right atrium60 . Complete absence of the portal venous system (CAPVS) is an extreme example of total failure of the vitelline veins to transform into the portal system, i.e. there is primary failure to form the critical anastomosis with the hepatic sinusoids or UVs (Figures 6 and 7). As a result, the enterohepatic circulation is disturbed and the portal venous blood is shunted systemically. Liver development is supplied by the hepatic arteries. Mesenteric and splenic venous blood may drain directly into the IVC, renal veins or hepatic veins, or via the caput medusa to the heart61 . Associated anomalies are frequent. Northrup et al.62 Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 99 reported heterotaxy–polysplenia in 25% of their cases, CHD in 30% (most frequently atrial septal defect and/or ventricular septal defect) and Goldenhar syndrome in 10%. Achiron et al.55 reported associated malformations, including trisomy 21, in four of their five cases. Incomplete absence of the portal venous system (IAPVS) or partial failure to form critical anastomoses may represent a more benign form of vitelline vein abnormality, and may result in agenesis of the right portal system, with a persistent left vitelline vein connected directly to the hepatic vein (portohepatic shunt) and an absent or preserved DV (Figure 8). Neonatal spontaneous resolution may occur. Achiron et al.55 reported four cases, none with associated malformations, in three of which the shunts resolved spontaneously postnatally55 . Prognosis of IAPVS depends on the presence of associated malformations and the development of hemodynamic imbalance with signs of heart failure, cardiomegaly and hydrops. As opposed to CAPVS, IAPVS is rarely associated with other malformations, and hemodynamic compromise depends on the intrahepatic shunt ratio, leading to IUGR63 . Hepatic bypass of the portal circulation is known to cause the so-called hepatic artery buffer effect, which compensates for the decreased portal supply by increasing blood flow in the hepatic artery. This results in a prominent Doppler signal55 , increased blood flow velocity, and decreased pulsatility index (PI) in the hepatic artery64 . Long term metabolic sequelae of portosystemic shunting have been reported in the postnatal literature and include: hypergalactosemia65 , hyperbilirubinemia, hyperammonemia66 , liver masses including focal nodular hyperplasia, adenoma, hepatoblastoma and hepatocellular carcinoma, and rarely encephalopathy67,68 . Anomalous pulmonary venous connection Anomalous pulmonary venous connection is a group of rare anomalies that may present in total or partial form. The combined incidence of anomalous pulmonary venous connection (APVC) has been reported as 6.8 : 100 000 livebirths69 or 4.9% of all CHD70 . Partial anomalous pulmonary venous connection Figure 6 (a) Tomographic ultrasound imaging (TUI) of the normal portal system. LPV, left portal vein; MPV, main portal vein; RAPV, right anterior portal vein; RPPV, right posterior portal vein. (b) TUI in a case of complete agenesis of the portal venous system. The arrow indicates the only remnant of the portal system. St, stomach. (c) High-definition power flow Doppler image of the sagittal plane showing that the ductus venosus (DV) is present; thus, the anomaly is not secondary to absent DV in this instance. The circle indicates the umbilical cord. Ao, aorta; CT, celiac trunk; IVC, inferior vena cava; LHV, left hepatic vein, UA, umbilical artery; UV, umbilical vein. Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Partial anomalous pulmonary venous connection (PAPVC) is a group of anomalies involving one or more, but not all, of the pulmonary veins connecting to the right atrium or a tributary (Figure 9)71 . An atrial septal defect is often present. There are several variations of this anomaly70,72 – 74 . (1) Right pulmonary veins to SVC (Figure 9a): usually the right upper and middle lung lobes drain into the SVC and atrial septal defect is present; occasionally the atrial septum is intact. Ultrasound Obstet Gynecol 2010; 36: 93–111. 100 Yagel et al. Figure 7 A case of complete agenesis of the portal venous system. (a) Transverse view of the fetal abdomen showing, beyond the stomach (St), the spleen (Sp), with the splenic vein coursing towards the right side of the body (blue) to form a confluence with the main portal vein. Note absence of the afferent intrahepatic venous system and enlarged IVC when compared with the aorta (red, arrow). (b) Pulsed Doppler insonation of the splenic vein–portal system junction depicting triphasic flow compatible with a systemic venous shunt. (c,d) Venography performed post-termination. In (c), note the umbilico-IVC shunt (arrow); (d) was taken 1 min later: the splenic vein (long black arrow) is shown to be confluent with the renal vein (short arrow) and with the superior mesenteric vein (double headed arrow), forming a conduit (dotted arrow, c) which became enlarged (white arrow) before shunting into the IVC. (Reproduced with permission from Achiron et al.55 ). (2) Right pulmonary veins to right atrium: veins from all right lung lobes drain directly into the right atrium, which can be dilated to as much as twice its normal size; there is usually an atrial septal defect. (3) Right pulmonary veins to IVC (Figure 9b): all or some right lung lobes are drained into the IVC; right lung Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. veins form a characteristic ‘fir-tree’ pattern; the atrial septum is intact. This variation is often seen with right lung hypoplasia, bronchial system anomalies, cardiac dextroposition, right pulmonary artery hypoplasia, anomalous arterial connection between the aorta and right lung and other cardiac anomalies. Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 101 Echocardiographic diagnosis of PAPVC is made by visualizing pulmonary veins connecting to the structure involved; Doppler studies are invaluable in identification and classification of this group of anomalies, and threedimensional (3D)/4D ultrasound modalities may have added value in their diagnosis74 – 76 . Total anomalous pulmonary venous connection Total anomalous pulmonary venous connection (TAPVC) involves complete disconnection between the pulmonary veins and the left atrium (Figure 10)71 . All the pulmonary veins drain into the right atrium or systemic veins. Onethird of cases present with an associated anomaly, while two thirds are isolated. TAPVC can be classified into four types71 : Type I: anomalous connection at the supracardiac level; Type II: anomalous connection at the cardiac level; Type III: anomalous connection at the infracardiac level; Type IV: connections at two or more of supracardiac, cardiac and infracardiac levels. Alternatively, this anomaly can be classed into two groups: (1) supradiaphragmatic type: pulmonary veins are connected to: the left innominate vein by the characteristic vertical vein, or the coronary sinus, the right atrium, or the SVC, without pulmonary venous obstruction; (2) infradiaphragmatic type: pulmonary veins drain into the portal vein or hepatic veins, with pulmonary venous obstruction. Figure 8 Incomplete absence of the portal venous system (IAPVS). Two different forms are shown: (a) absent right portal vein and portal sinus, showing X-shaped configuration formed by the umbilical vein (UV), left portal vein (LPV) branches and the ductus venosus (DV), in the standard transverse plane for abdominal circumference measurement; (b) dilated aberrant ‘horseshoe shaped’ arrangement of vessels encircling the right hepatic lobe. Ao, aorta; IVC, inferior vena cava; LPVi, left portal vein inferior branch; LPVm, left portal vein medial branch; SP, spine; St, stomach. (4) Left pulmonary veins to left innominate vein (Figure 9c): veins from only the upper left lobe, or all of the left lung, drain into the left innominate vein via an anomalous vertical vein; atrial septal defect is usually present. Left pulmonary drainage may alternately be to the coronary sinus, IVC, right SVC, right atrium or left subclavian vein, and may be associated with cardiac defects or polysplenia/asplenia or Turner or Noonan syndromes. (5) Left pulmonary veins to coronary sinus (Figure 9d), IVC, right SVC, right atrium or left subclavian vein; very rarely, the right pulmonary veins may connect to the azygos vein or coronary sinus. Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. There is usually an atrial septal defect. An obstruction in the pulmonary venous channel will impact the prognosis of TAPVC. One third of patients have an associated major anomaly, including cor bilocular, single ventricle, truncus arteriosus, transposition of the great arteries, pulmonary atresia, aortic coarctation, hypoplastic left ventricle, or anomalies of the systemic veins. TAPVC should be suspected when pulmonary veins cannot be visualized entering the left atrium in the four-chamber apical view plane, with a wide gap between the posterior wall of the left atrium and the descending aorta. In the supracardiac type, the right atrium volume overload causes enlargement of the atrium and a bowing leftwards of the interatrial septum. The common pulmonary channel may be visualized posterior to the left atrium with color Doppler, and this can be followed to the site of its connection. The ascending vertical vein to the left innominate vein can be seen in the 3VT view as an additional vessel to the left of the pulmonary artery. Doppler studies show the direction of blood flow in this vessel is cephalad, opposite to that in the SVC. In the infracardiac type, the descending vertical vein can be diagnosed in a transverse plane of the abdomen as an extra vessel in front of the descending aorta. In the sagittal Ultrasound Obstet Gynecol 2010; 36: 93–111. Yagel et al. 102 (a) (b) L. Inn. V. S.V.C. S.V.C. R.P.V. L.P.V. L.P.V. R.A. R.A. L.A. C.S. C.S. L.A. I.V.C. L.V. R.P.V. R.V. R.V. L.V. I.V.C. (c) (d) S.V.C. S.V.C. V. L. Inn. R.P.V. v.v. L.P.V. R.P.V. L.P.V. R.A. C.S. L.A. R.A. C.S. L.A. I.V.C. R.V. L.V. I.V.C. L.V. R.V. Figure 9 Common forms of partial anomalous pulmonary venous connection. (a) Anomalous connection of the right pulmonary veins (R.P.V.) to the superior vena cava (S.V.C.). There is usually a high or sinus venous defect. (b) Anomalous connections of the right pulmonary veins to the inferior vena cava (I.V.C.). The right lung commonly drains by one pulmonary vein without its usual anatomical divisions. Parenchymal abnormalities of the right lung are common and the atrial septum is usually intact. (c) Anomalous connection of the left pulmonary veins (L.P.V.) to the left innominate vein (L. Inn. V.) by way of a vertical vein (v.v.). There may be an additional left-to-right shunt through the atrial septal defect. (d) Anomalous connection of the L.P.V. to the coronary sinus (C.S.). L.A., left atrium; L.V., left ventricle; R.A., right atrium; R.V., right ventricle. (Reproduced with permission from Krabill and Lucas71 (Krabill KA, Lucas RV. In Heart Disease in Infants, Children, and Adolescents (5th edn), Moss AJ, Adams FH, Emmanouilides GC (eds). Williams and Wilkins: Baltimore, 1995; 841–849).) plane, the vertical vein courses cephalad between the IVC and the descending aorta, crossing the diaphragm (Figure 11). Doppler evaluation is key to the characterization of TAPVC to identify the anomalous connection. Turbulent flow will reveal the location of any obstruction and the degree of obstruction can be quantified70 – 72 . and the development of the pulmonary vascular bed. Isolated TAPVC, if detected and corrected surgically early in life, has an excellent outcome. Prognosis is poor when it is associated with other cardiac lesions and portal vein obstruction. In cases of TAPVC with obstruction in the anomalous venous channel, the neonate usually dies in the first weeks of postnatal life71,77 . Prognosis THE FETAL VENOUS SYSTEM IN PATHOLOGICAL CONDITIONS Prognosis in cases of PAPVC and TAPVC is affected by the presence of any cardiac or extracardiac malformations, the presence and size of the interatrial connection and any obstructive lesion in the anomalous connecting vessels, Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. In the physiology section of Part I of this review we emphasized the unique role of the venous system in maintaining a positive umbilicocaval pressure gradient. Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II S.V.C. (a) 103 L. Inn. V. (b) S.V.C. v.v. R.P.V. C.P.V. L.P.V. C.P.V. R.A. R.A. C.S. L.A. C.S. L.A. L.V. I.V.C I.V.C. R.V. R.V. L.V. (c) (d) S.V.C. S.V.C. C.P.V. L.P.V. R.A. R.A. R.P.V. L.A. C.S. C.S. I.V.C. I.V.C. R.V. L.V. L.V. R.V. I.V.C. L.H. R.H. D.V. L.P. R.P. P.V. S.V. S.M.V. Figure 10 Common forms of total anomalous pulmonary venous connection. (a) Anomalous connection of the pulmonary veins to the left innominate vein (L. Inn. V.) by way of a vertical vein (V.V.). (b) Anomalous connection to the coronary sinus (C.S.): the pulmonary veins join to form a confluence designated as the common pulmonary vein (C.P.V.), which connects to the C.S. (c) Anomalous connection to the right atrium (R.A.). The left and right pulmonary veins (L.P.V. and R.P.V.) usually enter the R.A. separately. (d) Anomalous connection to the portal vein (P.V.). The pulmonary veins form a confluence, from which an anomalous channel arises. This connects to the P.V., which communicates with the inferior vena cava (I.V.C.) by way of the ductus venosus (D.V.) or the hepatic sinusoids. L.A., left atrium; L.H., left hepatic vein; L.P., left portal vein; L.V., left ventricle; R.H., right hepatic vein; R.P., right left portal vein; R.V., right ventricle; S.M.V, superior mesenteric vein; S.V., splenic vein; S.V.C., superior vena cava. (Reproduced with permission from Krabill and Lucas71 (Krabill KA, Lucas RV. In Heart Disease in Infants, Children, and Adolescents (5th edn), Moss AJ, Adams FH, Emmanouilides GC (eds). Williams and Wilkins: Baltimore, 1995; 841–849).) This assures a low preload index, which is essential for optimal cardiac drainage. Cardiac output progressively increases and resistance of the placental vascular bed decreases while the umbilicocaval pressure gradient is maintained steady during the third trimester of pregnancy78 . Any situation hampering this hemodynamic balance initiates compensatory mechanisms in the arterial and venous systems. These compensatory mechanisms are Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. gradual and sequential, in correlation with the severity of the hypoxic insult, hence creating an efficient monitoring tool of evolving fetal distress. The most frequent pathological condition affecting the fetoplacental hemodynamic balance is placental dysfunction. Other etiologies are cardiac (malformations, arrhythmias, or increased preload blood volume) and conditions resulting in elevation of ventricular end-diastolic pressure, Ultrasound Obstet Gynecol 2010; 36: 93–111. 104 Yagel et al. Figure 11 Total anomalous pulmonary venous connection (infracardiac type) imaged in the sagittal plane. Tomographic ultrasound imaging was applied in post-processing and clearly shows the vertical vein draining into one of the hepatic veins. Ao, aorta; DV, ductus venosus; LHV, left hepatic vein; VV, vertical vein. atrial pressure and, consequently, precordial venous pressure. We focus here on uteroplacental insufficiency and the gradual hemodynamic changes that accompany its compromised vascular function. Reduced placental supply to the fetus initiates multiple compensatory vasodilatory mechanisms involving various arterial and venous systems. In the arterial system, the organ most widely studied and clinically evaluated is the brain (brain-sparing effect)79,80 . Evaluation of various parts of the arterial circulation in the fetus with circulatory compromise has been widely performed and reviewed elsewhere81 – 84 . The cascade of evolving circulatory compromise in uteroplacental insufficiency is characterized by hemodynamic changes in the placenta, heart and brain. The fetal circulation may be viewed as comprising two compartments, with the division at the aortic isthmus: the right ventricle/placenta, having high resistance, and the left ventricle/brain, having low resistance. The ratio between the Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. resistance indices (RI) of these two compartments has been used clinically as a monitoring tool of fetal compensatory mechanisms and the magnitude of hypoxic insult85 – 87 . The implications for the venous system of these changes in resistance in the different compartments are four-fold: reduced blood supply from the placenta to the liver, an increased proportion (also per unit of weight) of cardiac output diverted to the fetal body and consequently to the IVC, increased blood flow through the SVC resulting from the brain-sparing effect, and an increased afterload on the right ventricle. These hemodynamic changes lead to increased preload indices that hamper the supply of high-quality blood flow from the placenta. Venous compensatory mechanisms aim to improve the placental supply to the heart by increasing the proportion of DV shunting from the portal sinus. Human Doppler studies have reported variable results. Bellotti et al.88 found that the percentage of UV blood flow shunted through the DV increased from 26.5% in normally Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II grown fetuses to 90.3% in growth-restricted fetuses, with a consequent increased normalized blood flow volume from 30.8 mL/min/kg to 41.3 mL/min/kg. Others showed more moderate changes. Tchirikov et al.89 reported an increase from 43% to 62%, and Kiserud et al.90 reported an increase from 25% in normally grown to a mean of 39% in IUGR fetuses. They found that the degree of shunting in IUGR fetuses is positively correlated with the severity of placental insufficiency as reflected by the UA diastolic flow. A significant increase in shunting to the DV was found only in IUGR fetuses with UA-PI above the 97.5th percentile (35% blood shunted) and in those with absent/reversed diastolic flow (57% shunted)90 . Preferential flow through the DV results from reciprocal hemodynamic changes inside the liver. The presence of a sphincter in the isthmic portion of the DV has never been confirmed91 . Tchirikov et al.92 showed in vitro that rings derived from portal venous branches developed more force in reaction to catecholamines than did vascular rings obtained from the isthmic portion of the DV. In hypoxia, increased plasma catecholamine levels may evoke an increase in the DV shunting rate through differential contraction of the portal venous branches as compared to the DV. This effect may come into play, in addition to the active nitric oxide-mediated DV distension, which was shown experimentally92 . This intrahepatic shift of blood from the portal system to the DV during hypoxia was supported by an in-vivo Doppler study. Kessler et al.93 demonstrated that in IUGR fetuses with UA-PI above the 97.5th percentile, total liver perfusion is decreased equally to the left and right lobes. However, as placental insufficiency increased (as measured by the oxygen partial pressure in the UA), the proportion of left portal vein (LPV) contribution to the right lobe decreased, being replaced by increased flow from the main portal vein. In summary, placental vasculopathy leads to reduced umbilical flow to the heart. This initiates an intrahepatic compensatory mechanism, which consists of shifting blood from the liver to the DV. The liver plays a central role in regulating fetal growth. Reduced liver perfusion may provide the first clinical evidence of placental insufficiency, restricted fetal growth and decreased fetal weight. 105 of adverse outcome among growth-restricted fetuses are cardiomegaly, monophasic atrioventricular filling or holosystolic tricuspid regurgitation, and pulsations in the UV96 , while among hydropic fetuses they were UV and DV Doppler94 . This concurs with previous studies showing that in the temporal sequence of events prior to the appearance of abnormal fetal heart rate pattern, atonia or fetal demise, the arterial Doppler changes precede those of the venous system97 but are too early a sign to be used to time the decision to deliver. This was particularly evident in cases of early-onset IUGR, before 32 weeks of gestation84,98 . Adverse perinatal outcome is related to gestational age at delivery and the degree of placental insufficiency. Decision-making concerning the time of delivery aims to strike a balance between fetal injury related to prematurity, and that related to placental insufficiency99 . Results of the GRIT study100 indicated no significant difference in terms of stillbirth rate when delivery was immediate. However, this was refuted by findings at the 2-year follow up: the rate of cerebral palsy in the immediate delivery group was as expected (10%), while in the delayed delivery group it was 0%, suggesting that deferred delivery could be protective management101 . In a prospective multicenter study, Baschat et al.83 found that gestational age at delivery is the best predictor for intact survival until 29 weeks or 800 g estimated fetal weight, with sensitivities of 68% and 72%, respectively. Above these thresholds, DV Doppler parameters were shown to be the primary cardiovascular factor in predicting intact survival, and as such are the only parameters to use as a trigger for delivery. Doppler parameters Early response Decreased fetal growth Decreased AFI Decreased MPV resistance DOPPLER STUDIES OF THE FETAL VENOUS SYSTEM Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Hypoxia Increased UA resistance Decision point Doppler investigation is the only non-invasive in-utero method for assessing fetoplacental hemodynamic status. Each component of the fetomaternal circulation has a different role in placental function and fetal wellbeing. Doppler evaluation of the venous system aims to assess fetal cardiac function, which in severe cases may deteriorate to an acute event of congestive heart failure. The cardiovascular profile score94 – 96 combines sonographic markers of fetal cardiovascular status based on parameters found to be correlated with perinatal mortality. The parameters most strongly predictive Decreased UV flow volume Biophysical parameters Decreased fetal movement Increased venous pulsation Decreased fetal breathing movements DV A/RDF UV pulsations Late response FHR late decelerations/STV Acidosis Reduced fetal tone Figure 12 Suggested cascade of fetal circulatory compromise. Changes in Doppler and physiological parameters follow a temporal sequence82 . The decision point regards the timing of delivery. AFI, amniotic fluid index; A/RDF, absent or reversed diastolic flow; DV, ductus venosus; FHR, fetal heart rate; MPV, main portal vein; STV, short term variability; UA, umbilical artery; UV, umbilical vein. Ultrasound Obstet Gynecol 2010; 36: 93–111. Yagel et al. 106 Turan et al.82 found a well-ordered sequence of Doppler abnormalities in placental insufficiency (Figure 12), from early-onset ones, including increased UA resistance and brain-sparing effect, to late-onset ones, such as absent/reversed UA diastolic velocity, absent/reversed DV A-wave, and UV pulsation. The rate of progression through the sequence correlated significantly with gestational age: when appearing as early as 26–27 weeks of gestation, placental insufficiency was usually severe, progressing from one Doppler abnormality to the next in approximately 7–10 days. When Doppler abnormalities emerged near 30 weeks’ gestation, progression intervals were longer, up to 14 days, and clinically cases were milder. Doppler changes were limited to the arterial system, and the median age of delivery was 33 weeks. These findings, however, were in contrast with those of Arduini et al.85 , who showed that time intervals between arterial Doppler changes and delivery for late fetal heart rate decelerations were statistically significantly longer when Doppler abnormalities appeared before 29 weeks of gestation, compared with late-onset cases (mean interval between Doppler changes and delivery, 13.5 (range, 3–26) vs. 3 (range, 1–9) days. Other studies84,102 have shown that venous Doppler abnormalities preceded the appearance of late decelerations or reduced shortterm variability (< 2.2 ms) by 6–7 days. In conclusion, there is a well-documented sequence of biophysical and Doppler abnormalities that correspond with placental insufficiency and fetal growth restriction (Figure 12). Abnormalities in venous system Doppler waveforms are sensitive tools for the assessment of fetal well-being before 32 weeks’ gestation, and may help to fine-tune our decision-making concerning time of delivery in affected fetuses. Venous Doppler patterns Venous Doppler patterns in normal and IUGR fetuses have been established in large longitudinal and crosssectional studies; normal Doppler patterns were discussed in Part I of this review. Here we describe Doppler abnormalities seen in the most commonly investigated vessels (Figure 13). Umbilical vein Umbilical vein Doppler patterns are usually evaluated in the intra-abdominal portion of the vein. The sample volume should include the whole cross-section of the vessel, with an angle of insonation at or as close as possible to 0◦ . Since the IUGR state includes increased impedance in the fetoplacental circulation, reduced UV flow volume and velocity result. However, the considerable overlap with normal ranges precludes the usefulness of UV flow velocity as a measure of IUGR103 . The appearance of pulsatile flow in the UV is a simple and reliable marker of circulatory compromise, long recognized as a marker of asphyxia in small-forgestational age fetuses and in cases of non-immune Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. Figure 13 Abnormal Doppler waveforms in the umbilical vein (UV) (a), ductus venosus (b) and inferior vena cava (IVC) (c). (a) Abnormal UV waveform in hemodynamically compromised fetuses is characterized by the appearance of pulsations. (b) The DV normally has forward blood flow throughout the cardiac cycle. In compromised fetuses a drop in atrial systolic forward velocities is observed. As central venous pressure increases, blood flow may be reversed during atrial systole. (c) Abnormal IVC waveforms in intrauterine growth restriction show a decrease in forward flow during the S-wave (S) and D-wave (D) and accentuation of reversed flow in the A-wave (annotated ‘a’). As the condition deteriorates the D-wave may be reversed. hydrops104,105 . Pulsatility in the UV can result from two main sources of pressure waves: atrial contraction can cause a sharp deflection (notch) in UV flow, or a wave from the neighboring arterial flow, which will be traveling in the same direction, can cause an increment in the UV flow. The resulting pulsatile UV Doppler pattern may be only an A-wave notch or, in some severe cases, a triphasic waveform that mirrors the whole cardiac cycle may appear103 (Figure 13a). Ductus venosus Changes in DV flow are seen in hypoxia and hypovolemia in experimental animal models and in human fetuses106 – 110 . The DV is sampled at its inlet, with a large sample volume in a near-sagittal plane, at a low angle of insonation111,112 . Alternatively, DV flow can be sampled Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II in an oblique transverse section of the fetal abdomen. Normally at 20 weeks’ gestation about 30% of blood is shunted through the DV, while at 30 weeks about 20% of blood is shunted103,112 – 114 . In small-for-gestational age fetuses a much higher proportion of blood is shunted through the DV, and earlier placental compromise will show a more pronounced shunt and distension of the DV103 . Cardiac events are apparent in the DV waveform. Reversed or zero flow in the A-wave is a simple sign of disordered cardiac function. There is reduced velocity in the A-wave in IUGR, and as the situation worsens it is further deflected owing to increased afterload and preload, as well as increased end-diastolic pressure, the direct effects of hypoxia and increased adrenergic drive. Taken together, these effects produce an augmented atrial contraction and strong deflection during the A-wave in the DV waveform97,115,116 (Figure 13b). The combination of this and the DV distension, which lessens wave reflection at the junction with the UV by lessening the difference in the vessels’ diameters, produces a considerable effect on UV flow, and further deterioration leads to decreased velocity between the systolic and diastolic peaks. These waveform changes are most apparent in the second trimester and usually result from chromosomal aberration as opposed to cardiac decompensation115,117 – 120. Such changes are rarely observed in the third trimester, when improved endocrine control operates to attenuate them121 – 123 . Inferior vena cava The IVC is usually sampled in the fetal abdomen, caudal to the hepatic confluence and DV outlet, to avoid interference from neighboring vessels. Reference ranges for normal IVC flow parameters have been established124 – 126 . The IVC is the preferred vessel for postnatal evaluation of small-for-gestational age neonates and is familiar to pediatricians, so it is often sampled in the fetus. It is normal to observe a negative A-wave in the IVC because of the vessel’s normally relatively low velocities124 – 128 . In compromised fetuses, an abnormal IVC flow velocity waveform will show a decrease in forward flow during the S- and D-waves, and an accentuated reversed flow in the A-wave (Figure 13c). In severe cases the D-wave may be reversed. Hepatic and portal veins The hepatic vein, while easy to sample, is employed only infrequently as a parameter in IUGR studies. The signs of cardiac compromise observed in the hepatic vein are similar to those apparent in the DV and IVC129,130 . The left portal vein as the watershed of the fetal venous circulation. The LPV has been suggested as a simple marker of circulatory compromise131 – 133 . It is sampled in the left portal branch between the DV inlet and the junction with the main portal stem. Disturbed blood flow in the UA is indicative of increased resistance to blood flow in the right heart and right liver lobe. Under these Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. 107 pressures, flow in the LPV is reduced and may become pulsatile, bidirectional or reversed. If reversed, oxygen-poor blood from the spleen and gut will mix with oxygenated blood from the UV as it courses to the DV, supplying oxygen-poor blood to the fetal organs. Ultimately during reversal, more blood could be flowing through the DV than through the UV that supplies it, possibly creating suction on the LPV132 . Kilavuz et al.132 showed, in IUGR fetuses with absent or reversed end-diastolic flow in the UA, that while UV flow remained normal, LPV flow was normal in mildly affected fetuses, pulsatile in fetuses with increased RI or absent flow in the UA, and reversed in fetuses with reversed flow in the UA. There was a significant correlation between reversed flow in the LPV and increased RI in the UA. The normal distribution of blood flow between the left and right liver lobes is approximately 60%/40%. As described above, most UV blood (70–80%) perfuses the fetal liver, while 20–30% is shunted to the DV. Blood flow in the UV is directed to the left liver lobe and the DV, with only a minority diverted to the LPV and right liver lobe. Low or reversed flow in the left portal branch is an expression of prioritized umbilical perfusion of the left liver lobe at the expense of the right114 . CONCLUSION Congenital malformations of the venous system are a complex and varied group of lesions. There is much that we do not know about this system and its anomalies, but it is clear that knowledge of the embryonic development of affected vessels is key to understanding the in-utero progress and prognosis of these cases. Whenever anomalies of the cardinal, vitelline or umbilical system are diagnosed, they should prompt thorough investigation of the other segments of the cardiovascular system. It would appear that anomalies of the venous system are not as rare as formerly believed, and that more will be diagnosed if practitioners are cognizant of their sonographic appearance and associated anomalies. REFERENCES 1. Achiron R, Hegesh J, Yagel S, Lipitz S, Cohen SB, Rotstein Z. Abnormalities of the fetal central veins and umbilico-portal system: prenatal ultrasonographic diagnosis and proposed classification. Ultrasound Obstet Gynecol 2000; 16: 539–548. 2. Fasouliotis SJ, Achiron R, Kivilevitch Z, Yagel S. The human fetal venous system: normal embryologic, anatomic, and physiologic characteristics and developmental abnormalities. J Ultrasound Med 2002; 21: 1145–1158. 3. Lin AE, Ticho BS, Houde K, Westgate MN, Holmes LB. Heterotaxy: associated conditions and hospital-based prevalence in newborns. Genet Med 2000; 2: 157–172. 4. Berg C, Geipel A, Kohl T, Smrcek J, Germer U, Baschat AA, Hansmann M, Gembruch U. Fetal echocardiographic evaluation of atrial morphology and the prediction of laterality in cases of heterotaxy syndromes. Ultrasound Obstet Gynecol 2005; 26: 538–545. 5. Bowers PN, Brueckner M, Yost HJ. The genetics of left-right development and heterotaxia. Semin Perinatol 1996; 20: 577–588. Ultrasound Obstet Gynecol 2010; 36: 93–111. Yagel et al. 108 6. Vijayaraghavan SB, Raja V, Chitra TV. Interrupted inferior vena cava and left-sided subrenal inferior vena cava: prenatal diagnosis. J Ultrasound Med 2003; 22: 747–752. 7. Mihmanli I, Bulakbasi N, Kantarci F, Adaletli I, Pabuscu Y. The value of ultrasonography in interrupted inferior vena cava with azygos continuation. Eur J Ultrasound 2001; 14: 179–182. 8. Koc Z, Oguzkurt L. Interruption or congenital stenosis of the inferior vena cava: prevalence, imaging, and clinical findings. Eur J Radiol 2007; 62: 257–266. 9. Bartram U, Fischer G, Kramer HH. Congenitally interrupted inferior vena cava without other features of the heterotaxy syndrome: report of five cases and characterization of a rare entity. Pediatr Dev Pathol 2008; 11: 266–273. 10. Sheley RC, Nyberg DA, Kapur R. Azygous continuation of the interrupted inferior vena cava: a clue to prenatal diagnosis of the cardiosplenic syndromes. J Ultrasound Med 1995; 14: 381–387. 11. Biffi M, Boriani G, Frabetti L, Bronzetti G, Branzi A. Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10year experience. Chest 2001; 120: 139–144. 12. Galindo A, Gutierrez-Larraya F, Escribano D, Arbues J, Velasco JM. Clinical significance of persistent left superior vena cava diagnosed in fetal life. Ultrasound Obstet Gynecol 2007; 30: 152–161. 13. Guarnieri GF, Romano F, Clerico L, Balducci G. Absent right and persistent left superior vena cava: fetal and neonatal echocardiographic diagnosis. Pediatr Cardiol 2006; 27: 646–648. 14. Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respir Care 2000; 45: 411–416. 15. Freund M, Stoutenbeek P, ter Heide H, Pistorius L. ‘Tobacco pipe’ sign in the fetus: patent left superior vena cava with absent right superior vena cava. Ultrasound Obstet Gynecol 2008; 32: 593–594. 16. Pasquini L, Belmar C, Seale A, Gardiner HM. Prenatal diagnosis of absent right and persistent left superior vena cava. Prenat Diagn 2006; 26: 700–702. 17. Rizzo G, Arduini D, Capponi A. Use of the multiplanar display in evaluation of a persistent left superior vena cava in the fetal heart using 4-dimensional ultrasonography: advantage of adding the spin technique. J Ultrasound Med 2008; 27: 497–498. 18. Berg C, Knuppel M, Geipel A, Kohl T, Krapp M, Knöpfle G, Germer U, Hansmann M, Gembruch U. Prenatal diagnosis of persistent left superior vena cava and its associated congenital anomalies. Ultrasound Obstet Gynecol 2006; 27: 274–280. 19. Minniti S, Visentini S, Procacci C. Congenital anomalies of the venae cavae: embryological origin, imaging features and report of three new variants. Eur Radiol 2002; 12: 2040–2055. 20. Currarino G, Stannard MW, Kolni H. Umbilical vein draining into the inferior vena cava via the internal iliac vein, bypassing the liver. Pediatr Radiol 1991; 21: 265–266. 21. Hofstaetter C, Plath H, Hansmann M. Prenatal diagnosis of abnormalities of the fetal venous system. Ultrasound Obstet Gynecol 2000; 15: 231–241. 22. Jaeggi ET, Fouron JC, Hornberger LK, Proulx F, Oberhänsli I, Yoo SJ, Fermont L. Agenesis of the ductus venosus that is associated with extrahepatic umbilical vein drainage: prenatal features and clinical outcome. Am J Obstet Gynecol 2002; 187: 1031–1037. 23. Langman G, Wainwright H, Matthews L. Absence of the ductus venosus with direct connection between the umbilical vein and right atrium. Pediatr Dev Pathol 2001; 4: 298–303. 24. Leonidas JC, Fellows RA. Congenital absence of the ductus venosus: with direct connection between the umbilical vein and the distal inferior vena cava. AJR Am J Roentgenol 1976; 126: 892–895. 25. Siven M, Ley D, Hagerstrand I, Svenningsen N. Agenesis of the ductus venosus and its correlation to hydrops fetalis and Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. the fetal hepatic circulation: case reports and review of the literature. Pediatr Pathol Lab Med 1995; 15: 39–50. Sothinathan U, Pollina E, Huggon I, Patel S, Greenough A. Absence of the ductus venosus. Acta Paediatr 2006; 95: 620–621. Volpe P, Marasini M, Caruso G, Lituania M, Marzullo A, Volpe G, Gentile M. Prenatal diagnosis of ductus venosus agenesis and its association with cytogenetic/congenital anomalies. Prenat Diagn 2002; 22: 995–1000. Perles Z, Nir A, Nadjari M, Ergaz Z, Raas-Rothschild A, Rein AJ. Absent ductus venosus in the fetus: review of the literature and first report of direct umbilical venous drainage to the coronary sinus. Fetal Diagn Ther 2003; 18: 247–251. Acherman RJ, Evans WN, Galindo A, Collazos JC, Rothman A, Mayman GA, Luna CF, Rollins R, Kip KT, Berthody DP, Restrepo H. Diagnosis of absent ductus venosus in a population referred for fetal echocardiography: association with a persistent portosystemic shunt requiring postnatal device occlusion. J Ultrasound Med 2007; 26: 1077–1082. Contratti G, Banzi C, Ghi T, Perolo A, Pilu G, Visentin A. Absence of the ductus venosus: report of 10 new cases and review of the literature. Ultrasound Obstet Gynecol 2001; 18: 605–609. Berg C, Kamil D, Geipel A, Kohl T, Knöpfle G, Hansmann M, Gembruch U. Absence of ductus venosus – importance of umbilical venous drainage site. Ultrasound Obstet Gynecol 2006; 28: 275–281. Hoppen T, Hofstaetter C, Plath H, Kau N, Bartmann P. Agenesis of the ductus venosus and its correlation to hydrops fetalis. J Perinat Med 2000; 28: 69–73. Sau A, Sharland G, Simpson J. Agenesis of the ductus venosus associated with direct umbilical venous return into the heart–case series and review of literature. Prenat Diagn 2004; 24: 418–423. Gorincour G, Droulle P, Guibaud L. Prenatal diagnosis of umbilicoportosystemic shunts: report of 11 cases and review of the literature. AJR Am J Roentgenol 2005; 184: 163–168. Shen O, Valsky DVV, Messing B, Cohen SM, Lipschuetz M, Yagel S. Shunt diameter in agenesis of ductus venosus with extrahepatic porto-systemic shunt impacts prognosis. Ultrasound Obstet Gynecol (in press). DOI: 10.1002/uog.7702. Bell AD, Gerlis LM, Variend S. Persistent right umbilical vein–case report and review of literature. Int J Cardiol 1986; 10: 167–176. Hill LM, Mills A, Peterson C, Boyles D. Persistent right umbilical vein: sonographic detection and subsequent neonatal outcome. Obstet Gynecol 1994; 84: 923–925. Kinare AS, Ambardekar ST, Bhattacharya D, Pande SA. Prenatal diagnosis with ultrasound of anomalous course of the umbilical vein and its relationship to fetal outcome. J Clin Ultrasound 1996; 24: 333–338. Shen O, Tadmor OP, Yagel S. Prenatal diagnosis of persistent right umbilical vein. Ultrasound Obstet Gynecol 1996; 8: 31–33. Blazer S, Zimmer EZ, Bronshtein M. Persistent intrahepatic right umbilical vein in the fetus: a benign anatomic variant. Obstet Gynecol 2000; 95: 433–436. Kirsch CF, Feldstein VA, Goldstein RB, Filly RA. Persistent intrahepatic right umbilical vein: a prenatal sonographic series without significant anomalies. J Ultrasound Med 1996; 15: 371–374. Wolman I, Gull I, Fait G, Amster R, Kupferminc MJ, Lessing JB, Jaffa AJ. Persistent right umbilical vein: incidence and significance. Ultrasound Obstet Gynecol 2002; 19: 562–564. Greiss HB, McGahan JP. Umbilical vein entering the right atrium: significance of in utero diagnosis. J Ultrasound Med 1992; 11: 111–113. Jouk PS, Champetier J. Abnormal direct entry of the umbilical vein into the right atrium: antenatal detection, embryologic aspects. Surg Radiol Anat 1991; 13: 59–62. Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 45. Jeanty P. Persistent right umbilical vein: an ominous prenatal finding? Radiology 1990; 177: 735–738. 46. Monie IW, Nelson MM, Evans HM. Persistent right umbilical vein as a result of vitamin deficiency during gestation. Circ Res 1957; 5: 187–190. 47. De Catte L, Osmanagaoglu K, De Schrijver I. Persistent right umbilical vein in trisomy 18: sonographic observation. J Ultrasound Med 1998; 17: 775–779. 48. Byers BD, Goharkhay N, Mateus J, Ward KK, Munn MB, Wen TS. Pregnancy outcome after ultrasound diagnosis of fetal intra-abdominal umbilical vein varix. Ultrasound Obstet Gynecol 2009; 33: 282–286. 49. White SP, Kofinas A. Prenatal diagnosis and management of umbilical vein varix of the intra-amniotic portion of the umbilical vein. J Ultrasound Med 1994; 13: 992–994. 50. Mahony BS, McGahan JP, Nyberg DA, Reisner DP. Varix of the fetal intra-abdominal umbilical vein: comparison with normal. J Ultrasound Med 1992; 11: 73–76. 51. Sepulveda W, Mackenna A, Sanchez J, Corral E, Carstens E. Fetal prognosis in varix of the intrafetal umbilical vein. J Ultrasound Med 1998; 17: 171–175. 52. Allen SL, Bagnall C, Roberts AB, Teele RL. Thrombosing umbilical vein varix. J Ultrasound Med 1998; 17: 189–192. 53. Fung TY, Leung TN, Leung TY, Lau TK. Fetal intraabdominal umbilical vein varix: what is the clinical significance? Ultrasound Obstet Gynecol 2005; 25: 149–154. 54. Valsky DV, Rosenak D, Hochner-Celnikier D, Porat S, Yagel S. Adverse outcome of isolated fetal intra-abdominal umbilical vein varix despite close monitoring. Prenat Diagn 2004; 24: 451–454. 55. Achiron R, Gindes L, Kivilevitch Z, Kuint J, Kidron D, Boyanaover X, Yakobson J, Heggesh J. Prenatal diagnosis of congenital agenesis of the portal system. Ultrasound Obstet Gynecol 2009; 34: 643–652. 56. Goncalves LF, Sherer DM, Romero R, Silva M, Amundson GM, Treadwell MC. Prenatal sonographic findings of agenesis of the right and left portal veins and associated intrahepatic portosystemic shunts. J Ultrasound Med 1995; 14: 849–852. 57. Laverdiere JT, Laor T, Benacerraf B. Congenital absence of the portal vein: case report and MR demonstration. Pediatr Radiol 1995; 25: 52–53. 58. Manning N, Impey L, Lindsell D, Lakhoo K. Prenatally diagnosed portocaval shunt and postnatal outcome: a case report. Prenat Diagn 2004; 24: 537–540. 59. Venkat-Raman N, Murphy KW, Ghaus K, Teoh TG, Higham JM, Carvalho JS. Congenital absence of portal vein in the fetus: a case report. Ultrasound Obstet Gynecol 2001; 17: 71–75. 60. Morgan G, Superina R. Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. J Pediatr Surg 1994; 29: 1239–1241. 61. Niwa T, Aida N, Tachibana K, Shinkai M, Ohhama Y, Fujita K, Abe A, Lee J, Ozawa Y, Inoue T. Congenital absence of the portal vein: clinical and radiologic findings. J Comput Assist Tomogr 2002; 26: 681–686. 62. Northrup M, Mendez-Castillo A, Sethi Y, Churchill R. Congenital absence of the portal vein with an intrahepatic inferior vena cava branch showing hepatopetal flow. J Ultrasound Med 2002; 21: 569–572. 63. Delle Chiaie L, Neuberger P, Von Kalle T. Congenital intrahepatic portosystemic shunt: prenatal diagnosis and possible influence on fetal growth. Ultrasound Obstet Gynecol 2008; 32: 233–235. 64. Ebbing C, Rasmussen S, Godfrey KM, Hanson MA, Kiserud T. Hepatic artery hemodynamics suggest operation of a buffer response in the human fetus. Reprod Sci 2008; 15: 166–178. 65. Kim SZ, Marz PL, Laor T, Teitelbaum J, Jonas MM, Levy HL. Elevated galactose in newborn screening due to congenital absence of the portal vein. Eur J Pediatr 1998; 157: 608–609. Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. 109 66. Usuki N, Miyamoto T. A case of congenital absence of the intrahepatic portal vein diagnosed by MR angiography. J Comput Assist Tomogr 1998; 22: 728–729. 67. Matsuoka Y, Ohtomo K, Okubo T, Nishikawa J, Mine T, Ohno S. Congenital absence of the portal vein. Gastrointest Radiol 1992; 17: 31–33. 68. Grazioli L, Alberti D, Olivetti L, Rigamonti W, Codazzi F, Matricardi L, Fugazzola C, Chiesa A. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol 2000; 10: 820–825. 69. Correa-Villasenor A, Ferencz C, Boughman JA, Neill CA. Total anomalous pulmonary venous return: familial and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 1991; 44: 415–428. 70. Patel CR, Lane JR, Spector ML, Smith PC, Crane SS. Totally anomalous pulmonary venous connection and complex congenital heart disease: prenatal echocardiographic diagnosis and prognosis. J Ultrasound Med 2005; 24: 1191–1198. 71. Krabill KA, Lucas RV. Abnormal pulmonary venous connections. In Heart Disease in Infants, Children, and Adolescents (5th edn), Moss AJ, Adams FH, Emmanouilides GC (eds). Williams and Wilkins: Baltimore, 1995; 838–874. 72. Allan LD, Sharland GK. The echocardiographic diagnosis of totally anomalous pulmonary venous connection in the fetus. Heart 2001; 85: 433–437. 73. Valsangiacomo ER, Hornberger LK, Barrea C, Smallhorn JF, Yoo SJ. Partial and total anomalous pulmonary venous connection in the fetus: two-dimensional and Doppler echocardiographic findings. Ultrasound Obstet Gynecol 2003; 22: 257–263. 74. Espinoza J, Goncalves LF, Lee W, Mazor M, Romero R. A novel method to improve prenatal diagnosis of abnormal systemic venous connections using three- and four-dimensional ultrasonography and ‘inversion mode’. Ultrasound Obstet Gynecol 2005; 25: 428–434. 75. Yagel S, Cohen SM, Shapiro I, Valsky DV. 3D and 4D ultrasound in fetal cardiac scanning: a new look at the fetal heart. Ultrasound Obstet Gynecol 2007; 29: 81–95. 76. Sciaky-Tamir Y, Cohen SM, Hochner-Celnikier D, Valsky DV, Messing B, Yagel S. Three-dimensional power Doppler (3DPD) ultrasound in the diagnosis and follow-up of fetal vascular anomalies. Am J Obstet Gynecol 2006; 194: 274–281. 77. Venous abnormalities. In Clinical Synopsis of Mass and Adams’ Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult, Emmanouilides GC, Allen HD, Riemenschneider TA, Gutgesell HP (eds). Williams and Wilkins: Baltimore, 1998; 349–368. 78. Kessler J, Rasmussen S, Hanson M, Kiserud T. Longitudinal reference ranges for ductus venosus flow velocities and waveform indices. Ultrasound Obstet Gynecol 2006; 28: 890–898. 79. Wladimiroff JW, Tonge HM, Stewart PA. Doppler ultrasound assessment of cerebral blood flow in the human fetus. Br J Obstet Gynaecol 1986; 93: 471–475. 80. Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses. Am J Obstet Gynecol 1992; 166: 1262–1270. 81. Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008; 32: 274–280. 82. Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, Nicolaides KH, Harman CR, Baschat AA. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32: 160–167. 83. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Müller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007; 109: 253–261. 84. Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL. Temporal sequence of Ultrasound Obstet Gynecol 2010; 36: 93–111. Yagel et al. 110 85. 86. 87. 88. 89. 90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002; 19: 140–146. Arduini D, Rizzo G. Prediction of fetal outcome in small for gestational age fetuses: comparison of Doppler measurements obtained from different fetal vessels. J Perinat Med 1992; 20: 29–38. Hecher K, Spernol R, Stettner H, Szalay S. Potential for diagnosing imminent risk to appropriate- and small-forgestational-age fetuses by Doppler sonographic examination of umbilical and cerebral arterial blood flow. Ultrasound Obstet Gynecol 1992; 2: 266–271. Harrington K, Carpenter RG, Nguyen M, Campbell S. Changes observed in Doppler studies of the fetal circulation in pregnancies complicated by pre-eclampsia or the delivery of a small-for-gestational-age baby. I. Cross-sectional analysis. Ultrasound Obstet Gynecol 1995; 6: 19–28. Bellotti M, Pennati G, De Gasperi C, Bozzo M, Battaglia FC, Ferrazzi E. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growthrestricted human fetuses. Am J Obstet Gynecol 2004; 190: 1347–1358. Tchirikov M, Rybakowski C, Huneke B, Schroder HJ. Blood flow through the ductus venosus in singleton and multifetal pregnancies and in fetuses with intrauterine growth retardation. Am J Obstet Gynecol 1998; 178: 943–949. Kiserud T, Kessler J, Ebbing C, Rasmussen S. Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 2006; 28: 143–149. Mavrides E, Moscoso G, Carvalho JS, Campbell S, Thilaganathan B. The human ductus venosus between 13 and 17 weeks of gestation: histological and morphometric studies. Ultrasound Obstet Gynecol 2002; 19: 39–46. Tchirikov M, Schroder HJ, Hecher K. Ductus venosus shunting in the fetal venous circulation: regulatory mechanisms, diagnostic methods and medical importance. Ultrasound Obstet Gynecol 2006; 27: 452–461. Kessler J, Rasmussen S, Godfrey K, Hanson M, Kiserud T. Fetal growth restriction is associated with prioritization of umbilical blood flow to the left hepatic lobe at the expense of the right lobe. Pediatr Res 2009; 66: 113–117. Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 2006; 19: 407–413. Huhta JC. Fetal congestive heart failure. Semin Fetal Neonatal Med 2005; 10: 542–552. Makikallio K, Rasanen J, Makikallio T, Vuolteenaho O, Huhta JC. Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 48–54. Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides K. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies. Circulation 1995; 91: 129–138. Bilardo CM, Wolf H, Stigter RH, Ville Y, Baez E, Visser GH, Hecher K. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 2004; 23 119–125. Baschat AA, Gembruch U, Reiss I, Gortner L, Weiner CP, Harman CR. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2000; 16: 407–413. GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003; 110: 27–32. Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004; 364: 513–520. Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. 102. Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GH. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001; 18: 564–570. 103. Kiserud T. Venous flow in intrauterine growth restriction and cardiac decompensation. In Fetal Cardiology (2nd ed), Yagel S, Silverman NH, Gembruch U (eds). Informa Healthcare: New York, 2009; 547–560. 104. Gudmundsson S, Huhta JC, Wood DC, Tulzer G, Cohen AW, Weiner S. Venous Doppler ultrasonography in the fetus with nonimmune hydrops. Am J Obstet Gynecol 1991; 164: 33–37. 105. Lingman G, Laurin J, Marsal K. Circulatory changes in fetuses with imminent asphyxia. Biol Neonate 1986; 49: 66–73. 106. Behrman RE, Lees MH, Peterson EN, De Lannoy CW, Seeds AE. Distribution of the circulation in the normal and asphyxiated fetal primate. Am J Obstet Gynecol 1970; 108: 956–969. 107. Edelstone DI, Rudolph AM, Heymann MA. Effects of hypoxemia and decreasing umbilical flow liver and ductus venosus blood flows in fetal lambs. Am J Physiol 1980; 238: H656–H663. 108. Itskovitz J, LaGamma EF, Rudolph AM. Effects of cord compression on fetal blood flow distribution and O2 delivery. Am J Physiol 1987; 252: H100–H109. 109. Meyers RL, Paulick RP, Rudolph CD, Rudolph AM. Cardiovascular responses to acute, severe haemorrhage in fetal sheep. J Dev Physiol 1991; 15: 189–197. 110. Paulick RP, Meyers RL, Rudolph CD, Rudolph AM. Venous and hepatic vascular responses to indomethacin and prostaglandin E1 in the fetal lamb. Am J Obstet Gynecol 1990; 163: 1357–1363. 111. Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR. Ultrasonographic velocimetry of the fetal ductus venosus. Lancet 1991; 338: 1412–1414. 112. Kiserud T, Rasmussen S, Skulstad S. Blood flow and the degree of shunting through the ductus venosus in the human fetus. Am J Obstet Gynecol 2000; 182: 147–153. 113. Bellotti M, Pennati G, De Gasperi C, Battaglia FC, Ferrazzi E. Role of ductus venosus in distribution of umbilical blood flow in human fetuses during second half of pregnancy. Am J Physiol Heart Circ Physiol 2000; 279: H1256–H1263. 114. Kessler J, Rasmussen S, Godfrey K, Hanson M, Kiserud T. Longitudinal study of umbilical and portal venous blood flow to the fetal liver: low pregnancy weight gain is associated with preferential supply to the fetal left liver lobe. Pediatr Res 2008; 63: 315–320. 115. Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR, Simensen B. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol 1994; 4: 109–114. 116. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307–310. 117. Borrell A, Antolin E, Costa D, Farre MT, Martinez JM, Fortuny A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998; 179: 1612–1617. 118. Kiserud T. Hemodynamics of the ductus venosus. Eur J Obstet Gynecol Reprod Biol 1999; 84: 139–147. 119. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380–384. 120. Murta CG, Moron AF, Avila MA, Weiner CP. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002; 17: 308–314. 121. Hanson MA. Do we now understand the control of the fetal circulation? Eur J Obstet Gynecol Reprod Biol 1997; 75: 55–61. Ultrasound Obstet Gynecol 2010; 36: 93–111. The fetal venous system, Part II 122. Iwamoto HS, Kaufman T, Keil LC, Rudolph AM. Responses to acute hypoxemia in fetal sheep at 0.6–0.7 gestation. Am J Physiol 1989; 256: H613–H620. 123. Kiserud T, Jauniaux E, West D, Ozturk O, Hanson MA. Circulatory responses to maternal hyperoxaemia and hypoxaemia assessed non-invasively in fetal sheep at 0.3–0.5 gestation in acute experiments. BJOG 2001; 108: 359–364. 124. Hecher K, Campbell S, Snijders R, Nicolaides K. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 1994; 4: 381–390. 125. Huisman TW, Stewart PA, Wladimiroff JW. Flow velocity waveforms in the fetal inferior vena cava during the second half of normal pregnancy. Ultrasound Med Biol 1991; 17: 679–682. 126. Huisman TW, Stewart PA, Wladimiroff JW, Stijnen T. Flow velocity waveforms in the ductus venosus, umbilical vein and inferior vena cava in normal human fetuses at 12–15 weeks of gestation. Ultrasound Med Biol 1993; 19: 441–445. 127. Reed KL, Appleton CP, Anderson CF, Shenker L, Sahn DJ. Doppler studies of vena cava flows in human fetuses. Insights into normal and abnormal cardiac physiology. Circulation 1990; 81: 498–505. 128. Rizzo G, Arduini D, Romanini C. Inferior vena cava flow Copyright 2010 ISUOG. Published by John Wiley & Sons, Ltd. 111 129. 130. 131. 132. 133. 134. velocity waveforms in appropriate- and small-for-gestationalage fetuses. Am J Obstet Gynecol 1992; 166: 1271–1280. Hofstaetter C, Gudmundsson S, Dubiel M, Marsal K. Fetal right hepatic venous blood velocimetry in normal and high-risk pregnancies. Eur J Ultrasound 1996; 4: 153–160. Mari G, Uerpairojkit B, Copel JA. Abdominal venous system in the normal fetus. Obstet Gynecol 1995; 86: 729–733. Kiserud T, Kilavuz O, Hellevik LR. Venous pulsation in the fetal left portal branch: the effect of pulse and flow direction. Ultrasound Obstet Gynecol 2003; 21: 359–364. Kilavuz O, Vetter K, Kiserud T, Vetter P. The left portal vein is the watershed of the fetal venous system. J Perinat Med 2003; 31: 184–187. Kessler J, Rasmussen S, Kiserud T. The left portal vein as an indicator of watershed in the fetal circulation: development during the second half of pregnancy and a suggested method of evaluation. Ultrasound Obstet Gynecol 2007; 30: 757–764. Yagel S, Kivilevitch Z, Valsky DV, Achiron R. The fetal venous system: normal embryology, anatomy, and physiology and the development and appearance of anomalies. In Fetal Cardiology (2nd ed), Yagel S, Silverman NH, Gembruch U (eds). Informa Healthcare: New York, 2009; 413–426. Ultrasound Obstet Gynecol 2010; 36: 93–111.
© Copyright 2026 Paperzz